Counterfeiting and the Pharmaceutical Industry

Mui Y.Q. , “Crackdown targets counterfeit drugs”, Washington Post Nov. 20 (2009).

Everts S. , Chem. Eng. News 88(1), 27 (2010).

Newton P.N. Fernández F.M. Plançon A. Mildenhall D.C. Green M.D. Ziyong L. Christophel E.M. Phanouvong S. Howells S. McIntosh E. Laurin P. Blum N. Hampton C.Y. Faure K. Nyadong L. Soong C.W.R. Santoso B. Zhiguang W. Newton J. and Palmer K. , PLoS Med 5(2), e32 (2008).

Moreton C. , Pharm. Rev. 7(10), 12 (2009).

USP NF 2009. United States Pharmacopeia (2008).

EMEA, “Note for Guidance on the use of near infrared spectoscopy by the pharmaceutical industry and the data requirements for new sumissions and variations”, in 3309/01 (London, 2003).

Cockburn R. Newton P.N. Agyarko E.K. Akunyili D. and White N.J. , PLoS Med 2(4), e100 (2005).

Lodder R.A. Selby M. and Hieftje G.M. , Anal. Chem. 59(15), 1921 (1987).

Olsen B.A. Borer M.W. Perry F.M. and Forbes R.A. , Pharm. Technol. 26(6), 62 (2002).

Polli J.E. Hoag S.W. and Flank S. , Pharm. Technol. 33(8), 46 (2009).

Bate R. , Making a killing: The deadly implications of the counterfeit drug trade. AEI Press, Washington, DC, USA (2008).

Newton P.N. Lee S.J. Goodman C. Fernández F.M. Yeung S. Phanouvong S. Kaur H. Amin A.A. Whitty C.J.M. Kokwaro G.O. Lindegårdh N. Lukulay P. White L.J. Day N.P.J. Green M.D. and White N.J. , PLoS Med 6(3), e1000052 (2009).